SLU7 and acute myeloid leukemia: A fourth pathway would be the accumulation of several hits in signaling molecules, TFs, ERs and splicing factors, which induce either secondary AML after a chronic phase (Figure 5) or de novo AML; however, some so-called de novo AMLs with several ER mutations could actually be secondary to a non-detected chronic phase.